Center for Stem Cell Biology at Sloan Kettering retweetledi

Excited to share initial press release @BlueRockTx on promising results of Phase 1 trial in 12 PD patients bit.ly/3JCKneG. A major milestone on a 20+ year journey. Amazing leadership by @TabarViviane, @MSKCancerCenter & @BlueRockTx (@bigosi, Mark Tomishima & many more).
Viviane Tabar@TabarViviane
Data from Ph 1 trial of dopamine neuron grafts in patients with #Parkinsons are very promising: a long standing dream & lots of work;Excited for #Parkinson patients & proud of the team my lab led by JinghuaPiao @studerl lab,@MSKCancerCenter @BlueRockTx
English



